<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="189443">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00627211</url>
  </required_header>
  <id_info>
    <org_study_id>STHF Gastro BS1</org_study_id>
    <nct_id>NCT00627211</nct_id>
  </id_info>
  <brief_title>Carbon Dioxide Versus Air Insufflation in Oesophago-Gastro-Duodenoscopy (OGD)</brief_title>
  <official_title>A Double-Blinded, Randomized Trial Comparing Carbondioxide(CO2)and Air Insufflation in Oesophago-Gastro-Duodenoscopy (OGD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Norwegian Department of Health and Social Affairs</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Norwegian Department of Health and Social Affairs</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To achieve a satisfactory examination of the GI tract it needs to be distended during
      endoscopic procedures. After the examinations many patients complain of abdominal pain and
      discomfort. This pain has been substantially reduced by substituting room air with CO2 in
      both colonoscopies and ERCPs. The use of CO2 during colonoscopy has become routine practice
      at many endoscopy centers.

      In our study we will test the hypothesis that abdominal pain after gastroscopies also can be
      reduced by substituting room air with CO2.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>February 2008</start_date>
  <completion_date type="Anticipated">February 2009</completion_date>
  <primary_completion_date type="Anticipated">February 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double Blind (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain after OGD</measure>
    <time_frame>0-48 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain during OGD</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Room air</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>CO2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Room air insufflation through the endoscopy rack</intervention_name>
    <description>CO2 will be insufflated during oesophagogastroduodenoscopy in the intervention group, the control group will be examined with room air.</description>
    <arm_group_label>Room air</arm_group_label>
    <arm_group_label>CO2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>CO2 insufflation using an Olympus CO2 insufflator</intervention_name>
    <description>From the CO2 rack through the endoscopy rack CO2 will be insufflated to visualize the mucosa during oesophagogastroduodenoscopy.</description>
    <arm_group_label>CO2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled for OGD at the outpatient clinic of Telemark Hospital

        Exclusion Criteria:

          -  Age &lt;18

          -  Inability to give an informed concent

          -  Unsatisfactory norwegian language skills

          -  Patients not willing to participate

          -  COPD with dyspnoea NYHA 3-4
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>February 2008</verification_date>
  <lastchanged_date>February 28, 2008</lastchanged_date>
  <firstreceived_date>February 6, 2008</firstreceived_date>
  <responsible_party>
    <name_title>Geir Hoff MD PhD</name_title>
    <organization>Southern and Eastern Norway Health Authority board</organization>
  </responsible_party>
  <keyword>quality assessment</keyword>
  <keyword>pain reduction</keyword>
  <keyword>gastroscopy</keyword>
  <keyword>carbondioxide insufflation</keyword>
  <keyword>Patient satisfaction</keyword>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
